| Product Code: ETC9961631 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United States (US) Cancer Treatment Market Overview |
3.1 United States (US) Country Macro Economic Indicators |
3.2 United States (US) Cancer Treatment Market Revenues & Volume, 2021 & 2031F |
3.3 United States (US) Cancer Treatment Market - Industry Life Cycle |
3.4 United States (US) Cancer Treatment Market - Porter's Five Forces |
3.5 United States (US) Cancer Treatment Market Revenues & Volume Share, By Cancer Type, 2021 & 2031F |
3.6 United States (US) Cancer Treatment Market Revenues & Volume Share, By Treatment, 2021 & 2031F |
3.7 United States (US) Cancer Treatment Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.8 United States (US) Cancer Treatment Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 United States (US) Cancer Treatment Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing incidence of cancer cases in the United States |
4.2.2 Technological advancements in cancer treatment procedures |
4.2.3 Growing demand for personalized and targeted therapies |
4.2.4 Rising healthcare expenditure and insurance coverage |
4.2.5 Collaborations between pharmaceutical companies and research institutions for drug development |
4.3 Market Restraints |
4.3.1 High cost associated with cancer treatments |
4.3.2 Stringent regulatory requirements for drug approvals |
4.3.3 Limited accessibility to advanced cancer treatments in rural areas |
4.3.4 Shortage of healthcare professionals specialized in cancer care |
4.3.5 Side effects and toxicity of cancer treatments impacting patient quality of life |
5 United States (US) Cancer Treatment Market Trends |
6 United States (US) Cancer Treatment Market, By Types |
6.1 United States (US) Cancer Treatment Market, By Cancer Type |
6.1.1 Overview and Analysis |
6.1.2 United States (US) Cancer Treatment Market Revenues & Volume, By Cancer Type, 2021- 2031F |
6.1.3 United States (US) Cancer Treatment Market Revenues & Volume, By Breast Cancer, 2021- 2031F |
6.1.4 United States (US) Cancer Treatment Market Revenues & Volume, By Colorectal Cancer with Liver Metastases, 2021- 2031F |
6.1.5 United States (US) Cancer Treatment Market Revenues & Volume, By Lung Carcinoma, 2021- 2031F |
6.1.6 United States (US) Cancer Treatment Market Revenues & Volume, By Prostate Cancer, 2021- 2031F |
6.1.7 United States (US) Cancer Treatment Market Revenues & Volume, By Ovarian Cancer, 2021- 2031F |
6.1.8 United States (US) Cancer Treatment Market Revenues & Volume, By Head-And-Neck Cancer, 2021- 2031F |
6.1.9 United States (US) Cancer Treatment Market Revenues & Volume, By Glioblastoma, 2021- 2031F |
6.1.10 United States (US) Cancer Treatment Market Revenues & Volume, By Glioblastoma, 2021- 2031F |
6.2 United States (US) Cancer Treatment Market, By Treatment |
6.2.1 Overview and Analysis |
6.2.2 United States (US) Cancer Treatment Market Revenues & Volume, By Medication, 2021- 2031F |
6.2.3 United States (US) Cancer Treatment Market Revenues & Volume, By Targeted Therapies, 2021- 2031F |
6.2.4 United States (US) Cancer Treatment Market Revenues & Volume, By Radiotherapy, 2021- 2031F |
6.2.5 United States (US) Cancer Treatment Market Revenues & Volume, By Surgery, 2021- 2031F |
6.3 United States (US) Cancer Treatment Market, By Route of Administration |
6.3.1 Overview and Analysis |
6.3.2 United States (US) Cancer Treatment Market Revenues & Volume, By Injectable, 2021- 2031F |
6.3.3 United States (US) Cancer Treatment Market Revenues & Volume, By Oral, 2021- 2031F |
6.4 United States (US) Cancer Treatment Market, By End User |
6.4.1 Overview and Analysis |
6.4.2 United States (US) Cancer Treatment Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.3 United States (US) Cancer Treatment Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
7 United States (US) Cancer Treatment Market Import-Export Trade Statistics |
7.1 United States (US) Cancer Treatment Market Export to Major Countries |
7.2 United States (US) Cancer Treatment Market Imports from Major Countries |
8 United States (US) Cancer Treatment Market Key Performance Indicators |
8.1 Survival rates of cancer patients post-treatment |
8.2 Adoption rate of innovative cancer treatment technologies |
8.3 Patient satisfaction scores with cancer care services |
8.4 Number of clinical trials for new cancer therapies |
8.5 Rate of hospital readmissions for cancer patients |
9 United States (US) Cancer Treatment Market - Opportunity Assessment |
9.1 United States (US) Cancer Treatment Market Opportunity Assessment, By Cancer Type, 2021 & 2031F |
9.2 United States (US) Cancer Treatment Market Opportunity Assessment, By Treatment, 2021 & 2031F |
9.3 United States (US) Cancer Treatment Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.4 United States (US) Cancer Treatment Market Opportunity Assessment, By End User, 2021 & 2031F |
10 United States (US) Cancer Treatment Market - Competitive Landscape |
10.1 United States (US) Cancer Treatment Market Revenue Share, By Companies, 2024 |
10.2 United States (US) Cancer Treatment Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here